Table 1.
Authorized or approved vaccines as of April 2021.
| Vaccine name | Type | Countries approved | Efficacy |
|---|---|---|---|
| Cominarty | mRNA | Bahrain, Brazil, New Zealand, Saudi Arabia, Switzerland, WHO Countries | 91% |
| Moderna | mRNA | Switzerland, WHO Countries | >90% |
| Vaxzevria | Vector | Brazil | 76% |
| Johnson & Johnson | Vector | Bahrain, Brazil, Canada, Colombia, European Union, Denmark | 64-72% |
| Sputnik V | Vector | Russia | 92% |
| Sinovac | Inactivated | China | 50-91% |
| Convidecia | Protein | China, Chile, Hungary, Mexico, Pakistan | 65% |
| Covaxin | Inactivated | Botswana, Guatemala, Guyana, India, Iran, Mauritius, Mexico, Nepal, Nicaragua, Paraguay, Philippines, Zimbabwe | 78% |
| EpiVacCorona | Peptide | Turkmenistan Russia | Unknown |
| ZF2001 | Protein | China, Uzbekistan | Unknown |
| BBIBP-CorV | Inactivated | Bahrain, China, United Arab Emirates | 78% |
| Sinopharm | Inactivated | China | Unknown |
| QazVac | Inactivated | Kazakhstan | Unknown |
| CoviVac | Inactivated | Russia | Unknown |
Emergency use. Early use. Stopped use.